...
search icon
rgen-img

Repligen Corporation, Common Stock

RGEN

NSQ

$159.87

-$6.34

(-3.81%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.13B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
557.84K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.96
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$113.5 L
$211.13 H
$159.87

About Repligen Corporation, Common Stock

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameRGENSectorS&P500
1-Week Return-4.84%-0.46%0.38%
1-Month Return6.65%5.69%1.64%
3-Month Return14.58%0.07%5.64%
6-Month Return-1.44%0.03%16.44%
1-Year Return-18.48%3.12%22.25%
3-Year Return-19.4%10.61%34.76%
5-Year Return56.08%46.81%85.78%
10-Year Return594.78%109.43%194.65%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue366.26M670.53M801.54M638.76M632.36M[{"date":"2020-12-31","value":45.69,"profit":true},{"date":"2021-12-31","value":83.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.69,"profit":true},{"date":"2024-12-31","value":78.89,"profit":true}]
Cost of Revenue156.63M279.28M345.83M354.52M323.54M[{"date":"2020-12-31","value":44.18,"profit":true},{"date":"2021-12-31","value":78.78,"profit":true},{"date":"2022-12-31","value":97.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.26,"profit":true}]
Gross Profit209.63M391.25M455.71M284.25M308.83M[{"date":"2020-12-31","value":46,"profit":true},{"date":"2021-12-31","value":85.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.38,"profit":true},{"date":"2024-12-31","value":67.77,"profit":true}]
Gross Margin57.23%58.35%56.85%44.50%48.84%[{"date":"2020-12-31","value":98.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.44,"profit":true},{"date":"2023-12-31","value":76.26,"profit":true},{"date":"2024-12-31","value":83.7,"profit":true}]
Operating Expenses139.80M218.14M259.76M230.27M261.12M[{"date":"2020-12-31","value":53.54,"profit":true},{"date":"2021-12-31","value":83.54,"profit":true},{"date":"2022-12-31","value":99.48,"profit":true},{"date":"2023-12-31","value":88.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income42.54M133.50M133.61M54.58M47.70M[{"date":"2020-12-31","value":31.84,"profit":true},{"date":"2021-12-31","value":99.92,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":40.85,"profit":true},{"date":"2024-12-31","value":35.7,"profit":true}]
Total Non-Operating Income/Expense(22.74M)(26.42M)(8.51M)6.64M-[{"date":"2020-12-31","value":-342.2,"profit":false},{"date":"2021-12-31","value":-397.59,"profit":false},{"date":"2022-12-31","value":-128.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income59.22M153.54M219.14M64.13M56.71M[{"date":"2020-12-31","value":27.02,"profit":true},{"date":"2021-12-31","value":70.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":29.27,"profit":true},{"date":"2024-12-31","value":25.88,"profit":true}]
Income Taxes(709.00K)25.25M33.18M22.55M21.11M[{"date":"2020-12-31","value":-2.14,"profit":false},{"date":"2021-12-31","value":76.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.98,"profit":true},{"date":"2024-12-31","value":63.62,"profit":true}]
Income After Taxes59.93M128.29M185.96M41.58M-[{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.36,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations59.93M128.29M185.96M115.79M-[{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.27,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income59.93M128.29M185.96M41.58M35.60M[{"date":"2020-12-31","value":32.23,"profit":true},{"date":"2021-12-31","value":68.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.36,"profit":true},{"date":"2024-12-31","value":19.14,"profit":true}]
EPS (Diluted)1.663.063.281.730.60[{"date":"2020-12-31","value":50.61,"profit":true},{"date":"2021-12-31","value":93.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.74,"profit":true},{"date":"2024-12-31","value":18.24,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RGEN
Cash Ratio 7.23
Current Ratio 10.44
Quick Ratio 8.76

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RGEN
ROA (LTM) 0.20%
ROE (LTM) -0.10%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RGEN
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RGEN
Trailing PE NM
Forward PE 104.17
P/S (TTM) 14.00
P/B 4.62
Price/FCF 212
EV/R 14.38
EV/Ebitda 87.67
PEG 2.59

FAQs

What is Repligen Corporation share price today?

Repligen Corporation (RGEN) share price today is $159.87

Can Indians buy Repligen Corporation shares?

Yes, Indians can buy shares of Repligen Corporation (RGEN) on Vested. To buy Repligen Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RGEN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Repligen Corporation be purchased?

Yes, you can purchase fractional shares of Repligen Corporation (RGEN) via the Vested app. You can start investing in Repligen Corporation (RGEN) with a minimum investment of $1.

How to invest in Repligen Corporation shares from India?

You can invest in shares of Repligen Corporation (RGEN) via Vested in three simple steps:

  • Click on Sign Up or Invest in RGEN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Repligen Corporation shares
What is Repligen Corporation 52-week high and low stock price?

The 52-week high price of Repligen Corporation (RGEN) is $211.13. The 52-week low price of Repligen Corporation (RGEN) is $113.5.

What is Repligen Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Repligen Corporation (RGEN) is 4.62

What is the Market Cap of Repligen Corporation?

The market capitalization of Repligen Corporation (RGEN) is $9.13B

What is Repligen Corporation’s stock symbol?

The stock symbol (or ticker) of Repligen Corporation is RGEN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top